Reuters Science News Summary
Following is a summary of current science news briefs.
Does drug touted by Trump work on COVID-19? After data debacle, we still don't know
Scientists are resuming COVID-19 trials of the now world-famous drug hydroxychloroquine, as confusion continues to reign about the anti-malarial hailed by U.S. President Donald Trump as a potential "game-changer" in fighting the pandemic. The renewed research push follows widespread criticism of the quality of data in a study that on Thursday was retracted. The article, originally published in influential medical journal The Lancet, had found high risks associated with the treatment.
ALSO READ
-
Prospects of a New Summit: South Korean Optimism Amid Uncertainty
-
Nomination Turbulence: White House Withdraws Jeffrey Anderson for ICAO Post
-
Potential EU Partnerships Stir International Debate
-
Trump's Rate War with the Fed: A High-Stakes Economic Drama
-
Trump's Bold Move: Meeting with Venezuela's Interim Leader
Google News